What is the address of NZASENGA AKAYESU MED?

The registered office of NZASENGA AKAYESU MED is located at Rue François-Boudart 13, 6700 Arlon.

Is NZASENGA AKAYESU MED still active?

Yes. According to the CBE (30 September 2026) NZASENGA AKAYESU MED is active, legal situation “Normale toestand”, started on 30 November 2023.

Is NZASENGA AKAYESU MED registered on Peppol?

Yes, NZASENGA AKAYESU MED is registered on the Peppol network with ID 0208:1002838854.

What is the enterprise number of NZASENGA AKAYESU MED?

The enterprise number of NZASENGA AKAYESU MED is BE1002838854.

When was NZASENGA AKAYESU MED founded?

NZASENGA AKAYESU MED was founded on 30 November 2023.

Who are the directors of NZASENGA AKAYESU MED?

According to the 2025 annual accounts, the directors of NZASENGA AKAYESU MED are: SYLVIE NZASENGA.

Is NZASENGA AKAYESU MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 November 2023; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NZASENGA AKAYESU MED make in 2025?

NZASENGA AKAYESU MED posted a profit after taxes of € 38,545 in financial year 2025.

What is the revenue of NZASENGA AKAYESU MED?

As a small company, NZASENGA AKAYESU MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 97,248.

NZASENGA AKAYESU MED (Private Limited) - Arlon

Dossier NZASENGA AKAYESU MED, printed on 30 September 2026 from databakkes.be/en/1002838854/nzasenga-akayesu-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

NZASENGA AKAYESU MED from Arlon, company number BE1002838854, closed financial year 2025 with a result of € 38,545 after tax. For that financial year NZASENGA AKAYESU MED recorded a gross margin of € 97,248 and equity of € 114,977. Compared with financial year 2024, the result moved from € 75,432 to € 38,545. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Growing

€ 114,977

▲ 50% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 38,545

▼ 49% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 78,283

▼ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 113,977.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 70,036

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 219,522

▲ 132% vs 2024

€ 30,240 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 1,801

▲ 190% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 4,148

▼ 83% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 121,847 Gross margin 2024: € 121,847 First fiscal year in the series	€ 97,248 Gross margin 2025: € 97,248 ▼ 20% vs 2024 (€ 121,847) Unfavourable step	▼ 20%
Profit after taxes	€ 75,432 Profit after taxes 2024: € 75,432 First fiscal year in the series	€ 38,545 Profit after taxes 2025: € 38,545 ▼ 49% vs 2024 (€ 75,432) Unfavourable step	▼ 49%
Equity	€ 76,432 Equity 2024: € 76,432 First fiscal year in the series	€ 114,977 Equity 2025: € 114,977 ▲ 50% vs 2024 (€ 76,432) Favourable step	▲ 50%
Total debts	€ 119,510 Total debts 2024: € 119,510 First fiscal year in the series	€ 227,170 Total debts 2025: € 227,170 ▲ 90% vs 2024 (€ 119,510) Unfavourable step	▲ 90%
Cash	€ 92,257 Cash 2024: € 92,257 First fiscal year in the series	€ 78,283 Cash 2025: € 78,283 ▼ 15% vs 2024 (€ 92,257) Unfavourable step	▼ 15%
Land & buildings	-	€ 148,521 Land & buildings 2025: € 148,521 First fiscal year in the series
Retained profit	€ 75,432 Retained profit 2024: € 75,432 First fiscal year in the series	€ 113,977 Retained profit 2025: € 113,977 ▲ 51% vs 2024 (€ 75,432) Favourable step	▲ 51%
Bank debt	€ 94,609 Bank debt 2024: € 94,609 First fiscal year in the series	€ 219,522 Bank debt 2025: € 219,522 ▲ 132% vs 2024 (€ 94,609) Unfavourable step	▲ 132%
Balance sheet total	€ 195,942 Balance sheet total 2024: € 195,942 First fiscal year in the series	€ 342,147 Balance sheet total 2025: € 342,147 ▲ 75% vs 2024 (€ 195,942) Unchanged	▲ 75%

Key figures of NZASENGA AKAYESU MED, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NZASENGA AKAYESU MED?

What happened at NZASENGA AKAYESU MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 38,545 (▼ 49% vs 2024). Source: NBB ↗
Nov 30, 2023 New establishment in Arlon. KBO
Nov 30, 2023 Start of the company according to the CBE. KBO

In short

From € 75,432 profit in 2024 to € 38,545 profit in 2025.

Paid € 31,102 in corporate taxes since 2024.

Best year ever: 2024, with € 75,432 profit.

Original PDFs at the National Bank ↗

A new publication or filing at NZASENGA AKAYESU MED? We notify you, reason included.

Follow NZASENGA AKAYESU MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SYLVIE NZASENGA

NZASENGA AKAYESU MED

Behind NZASENGA AKAYESU MED is SYLVIE NZASENGA.

See the full network in the app

Directors

According to the 2025 annual accounts

SYLVIE NZASENGA

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue François-Boudart 13

6700 Arlon

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1002.838.854
VAT number: BE 1002.838.854
Registered office: Rue François-Boudart 13, 6700 Arlon
Names & denominations: NZASENGA AKAYESU MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 November 2023
Peppol: Active · Active since 6 Jan 2026
Contact: [email protected] +32492429085

View on CBE Public ↗ Annual accounts (NBB) ↗